Addex Therapeutics Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CHF 844,223 compared to CHF 904,060 a year ago. Operating loss was CHF 3.148 million compared to CHF 4.272 million a year ago. Net loss was CHF 2.639 million compared to CHF 4.305 million a year ago. Basic loss per share from continuing operations was CHF 0.08 compared to CHF 0.16 a year ago.